Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

Similar articles for PubMed (Select 23363758)

1.

[Analysis of clinical characteristics and JAK2V617F mutation of Tibetan people living at high altitudes with polycythemia].

Tang DJ, Ye YX, Li J.

Zhonghua Xue Ye Xue Za Zhi. 2012 Nov;33(11):960-2. Chinese. No abstract available.

2.

[Clinical study on relationship between protein tyrosine kinase JAK2 V617F mutation and high altitude polycythemia].

Ji LH, Li ZQ, Cui S.

Zhonghua Xue Ye Xue Za Zhi. 2012 Apr;33(4):319-20. Chinese. No abstract available.

3.

Usefulness of JAK2V617F mutation in distinguishing idiopathic erythrocytosis from polycythemia vera.

Rossi D, Cortini F, Deambrogi C, Barbieri C, Cerri M, Franceschetti S, Conconi A, Capello D, Gaidano G.

Leuk Res. 2007 Jan;31(1):97-101. Epub 2006 Apr 18.

PMID:
16620973
4.

Isolated erythrocythemia: a distinct entity or a sub-type of polycythemia vera?

Ohyashiki K, Kiguchi T, Ito Y, Gotoh A, Tauchi T, Miyazawa K, Kimura Y, Hisatomi H, Ohyashiki JH.

Jpn J Clin Oncol. 2008 Mar;38(3):230-2. doi: 10.1093/jjco/hym174. Epub 2008 Feb 21. No abstract available.

5.

Isolated erythrocytosis in V617F negative patients with JAK2 exon 12 mutations: report of a new mutation.

Bernardi M, Ruggeri M, Albiero E, Madeo D, Rodeghiero F.

Am J Hematol. 2009 Apr;84(4):258-60. doi: 10.1002/ajh.21357. No abstract available.

PMID:
19229983
6.

Serum levels of granulocyte colony-stimulating factor in JAK2 V617F-positive vs. negative erythrocytosis.

Fujita H, Hamaki T, Ohwada A, Tomiyama J, Nishimura S.

Int J Lab Hematol. 2011 Dec;33(6):e20-1. doi: 10.1111/j.1751-553X.2011.01336.x. Epub 2011 Jun 6. No abstract available.

PMID:
21645282
7.

[Correlations of JAK2V617F point mutation with clinical and laboratory features in patients with polycythemia vera].

Shen YF, Xia J, Lu MZ, Jiang YQ.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Feb;17(1):121-4. Chinese.

PMID:
19236761
8.

Infrequent occurrence of mutations in the PH domain of LNK in patients with JAK2 mutation-negative 'idiopathic' erythrocytosis.

Spolverini A, Pieri L, Guglielmelli P, Pancrazzi A, Fanelli T, Paoli C, Bosi A, Nichele I, Ruggeri M, Vannucchi AM.

Haematologica. 2013 Sep;98(9):e101-2. doi: 10.3324/haematol.2013.090175. Epub 2013 Jun 28. No abstract available.

9.

Detection of JAK2 exon 12 mutations in 15 patients with JAK2V617F negative polycythemia vera.

Schnittger S, Bacher U, Haferlach C, Geer T, Müller P, Mittermüller J, Petrides P, Schlag R, Sandner R, Selbach J, Slawik HR, Tessen HW, Wehmeyer J, Kern W, Haferlach T.

Haematologica. 2009 Mar;94(3):414-8. doi: 10.3324/haematol.13223.

10.

Detection of the JAK2V617F mutation in patients with slightly elevated platelets or hemoglobin without a secondary cause.

Strobbe L, Lestrade P, Hermans MH, Fijnheer R.

Ann Hematol. 2007 Nov;86(11):801-3. Epub 2007 Aug 17.

PMID:
17703302
11.

High percentage of JAK2 exon 12 mutation in Asian patients with polycythemia vera.

Yeh YM, Chen YL, Cheng HY, Su WC, Chow NH, Chen TY, Ho CL.

Am J Clin Pathol. 2010 Aug;134(2):266-70. doi: 10.1309/AJCPK7KGOWPHYWM0.

12.

A genetic mechanism for Tibetan high-altitude adaptation.

Lorenzo FR, Huff C, Myllymäki M, Olenchock B, Swierczek S, Tashi T, Gordeuk V, Wuren T, Ri-Li G, McClain DA, Khan TM, Koul PA, Guchhait P, Salama ME, Xing J, Semenza GL, Liberzon E, Wilson A, Simonson TS, Jorde LB, Kaelin WG Jr, Koivunen P, Prchal JT.

Nat Genet. 2014 Sep;46(9):951-6. doi: 10.1038/ng.3067. Epub 2014 Aug 17.

PMID:
25129147
13.

[JAK2V617F mutation in the patients with myeloproliferative disorder and its relation with clinical characteristics].

Zhu JF, Liu Y, Liu P, Jia MF, Cheng J, Zhao L.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011 Aug;19(4):916-20. Chinese.

PMID:
21867614
14.

Janus kinase (JAK) 2 V617F mutation in Asian Indians with cerebral venous thrombosis and without overt myeloproliferative disorders.

De T, Prabhakar P, Nagaraja D, Christopher R.

J Neurol Sci. 2012 Dec 15;323(1-2):178-82. doi: 10.1016/j.jns.2012.09.012. Epub 2012 Sep 30.

PMID:
23031663
15.

[Clinical characteristics and changes in blood electrolyte and renal function of neonates with polycythemia at high altitude].

Deji MD, Shan MN, Zhang YL, Qun Y, Zhao M.

Zhonghua Er Ke Za Zhi. 2011 Oct;49(10):793-5. Chinese.

PMID:
22321189
16.

JAK2 exon 12 mutation in JAK2V617F-negative polycythemia vera.

Röthlisberger B, Huber A, Bargetzi M, Mendez A, Heizmann M.

Leuk Lymphoma. 2008 Mar;49(3):586-8. doi: 10.1080/10428190701861652. No abstract available.

PMID:
18297539
17.

JAK2V617F mutation is common in old patients with polycythemia vera and essential thrombocythemia.

Randi ML, Ruzzon E, Tezza F, Scapin M, Duner E, Scandellari R, Fabris F.

Aging Clin Exp Res. 2011 Feb;23(1):17-21.

PMID:
21499015
18.

[Correlation of JAK2V617F mutation burden with clinical features in patients with polycythemia vera and essential thrombocythemia].

Liu HX, Tong CR, Cai P, Teng W, Wang H, Zhang Y, Zhu P.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Jun;17(3):742-5. Chinese.

PMID:
19549399
19.

JAK2 V617F mutation is associated with increased risk of thrombosis in Chinese patients with essential thrombocythaemia.

Wong RS, Cheng CK, Chan NP, Cheng SH, Wong WS, Lau KM, Cheng G, Ng MH.

Br J Haematol. 2008 Jun;141(6):902-4. doi: 10.1111/j.1365-2141.2008.07127.x. Epub 2008 Apr 10. No abstract available.

PMID:
18410451
20.

JAK2 exon 12 mutations in polycythemia vera or idiopathic erythrocytosis.

Martínez-Avilés L, Besses C, Alvarez-Larrán A, Cervantes F, Hernández-Boluda JC, Bellosillo B.

Haematologica. 2007 Dec;92(12):1717-8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk